Related Experiment Video
Updated: Jul 14, 2026
09:52
Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Pulmonary aspergillosis: a clinical update
1Division of Pulmonary, Allergy, Critical Care and Sleep, Harper University Hospital, 3990 John R-3 Hudson, Detroit, MI 48201, USA.
Summary
Pulmonary aspergillosis encompasses diverse conditions like invasive, chronic, and allergic forms, influenced by immune status. Advances in diagnostics and new antifungal drugs improve patient outcomes for these Aspergillus-related lung diseases.
Area of Science:
- Pulmonology
- Infectious Diseases
- Mycology
Background:
- Aspergillus species cause various pulmonary diseases, including invasive pulmonary aspergillosis, chronic necrotizing aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis.
- Disease presentation and severity depend on patient immune status and underlying lung conditions.
Purpose of the Study:
- To provide a clinical update on the epidemiology, risk factors, clinical presentation, diagnosis, and management of pulmonary aspergillosis.
- To highlight recent advances in diagnostic methods and antifungal therapies.
Main Methods:
- Review of current literature on pulmonary aspergillosis.
- Synthesis of information on diagnostic tools and therapeutic agents.
Main Results:
- Pulmonary aspergillosis manifests differently based on host factors, ranging from invasive to allergic forms.
- New non-invasive diagnostic tests and novel antifungal agents (azoles, echinocandins) are improving patient management and outcomes.
Conclusions:
- Pulmonary aspergillosis requires tailored management strategies based on specific clinical syndromes and patient immune status.
- Recent advancements in diagnostics and therapeutics offer improved prospects for patients with these fungal lung infections.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.